Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
6M
-
Shares change
-
+5.35M
-
Total reported value, excl. options
-
$14.1M
-
Value change
-
+$12.6M
-
Number of buys
-
8
-
Number of sells
-
-2
-
Price
-
$2.35
Significant Holders of Protalix BioTherapeutics, Inc. - COM (PLX) as of Q1 2020
16 filings reported holding PLX - Protalix BioTherapeutics, Inc. - COM as of Q1 2020.
Protalix BioTherapeutics, Inc. - COM (PLX) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6M shares
.
Largest 10 shareholders include HIGHBRIDGE CAPITAL MANAGEMENT LLC (4.83M shares), RENAISSANCE TECHNOLOGIES LLC (477K shares), Psagot Investment House Ltd. (406K shares), BRIDGEWAY CAPITAL MANAGEMENT INC (89.5K shares), CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM (66.6K shares), JANE STREET GROUP, LLC (50.4K shares), Measured Wealth Private Client Group, LLC (38.1K shares), SG Americas Securities, LLC (22.5K shares), GROUP ONE TRADING, L.P. (5.97K shares), and FEDERATED HERMES, INC. (5.76K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.